SCHEMBL1682943

SCHEMBL1682943

Cn1ccnc1[S]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL308400 0.71 LPO (0.55) —
SCHEMBL31153305 0.69 LPO (0.52) —
Hydrochloric Acid SCHEMBL1806963 0.69 LPO (0.52) —
SCHEMBL15149 0.69 — —
SCHEMBL16694847 0.69 — —
SCHEMBL13052883 0.69 LPO (0.46) —
SCHEMBL16719314 0.67 LPO (0.44) —
SCHEMBL7352436 0.67 — —
SCHEMBL51531 0.67 — —
SCHEMBL8072158 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148995-B1 6-SUBSTITUTED-3H-1,3-BENZOTHIAZOL-2-ONE COMPOUNDS AS TARP-GAMMA 8 DEPENDENT AMPA RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2020-09-23 — — EP claimed
EP-2303283-A2 ANTI-CANCER COMBINATION THERAPY Katholieke Universiteit Leuven K.U. Leuven R&D (BE) 2011-04-06 — — EP claimed
US-20110065663-A1 ANTI-CANCER COMBINATION THERAPY KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D 2011-03-17 — — US claimed
WO-2009138507-A2 ANTI-CANCER COMBINATION THERAPY KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2009-11-19 — — WO claimed
US-20070099917-A1 Novel inhibitors and methods for their preparation THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2007-05-03 — — US claimed
US-20070066614-A1 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2007-03-22 — — US claimed
US-7173030-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2007-02-06 — — US claimed
EP-1631558-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE I BIOVITRUM AB (SE) 2006-03-08 — — EP claimed
EP-0739891-B1 Substituted heterocycles ASTRAZENECA AB (SE) 2005-01-19 — — EP claimed
US-20050009821-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB 2005-01-13 — — US claimed
EP-0680962-A2 Heterocyclic compounds ZENECA LIMITED (GB) 1995-11-08 — — EP claimed
WO-1995016682-A1 CYCLIC AMIDE DERIVATIVES AS NEUROKININ A ANTAGONISTS ZENECA LIMITED (GB) 1995-06-22 — — WO claimed
US-4988681-A Dipeptidase inhibitore; reducing renal toxicity; prevention deactivation of (carba)penem antibiotics BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-01-29 — — US claimed
WO-1990001479-A1 4,5-DIHYDRO-3(2H)-PYRIDAZINONES, PROCESS FOR PRODUCING THEM AND THEIR USE CASSELLA AKTIENGESELLSCHAFT (DE) 1990-02-22 — — WO claimed
EP-0347840-A2 Phosphinic acid derivates BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-12-27 — — EP claimed
US-4701206-A Herbicidal sulfonylureas CIBA-GEIGY CORPORATION (US) 1987-10-20 — — US claimed
EP-0038541-B1 NOVEL PRODRUGS OF BIOLOGICALLY ACTIVE AGENTS CONTAINING MERCAPTO GROUPS, PROCESS FOR PREPARING AND THERAPEUTICALLY EFFECTIVE COMPOSITION CONTAINING THE SAME MERCK & CO. INC. (US) 1986-08-13 — — EP claimed
US-4602936-A Herbicidal sulfonylureas CIBA-GEIGY CORPORATION (US) 1986-07-29 — — US claimed
EP-0141777-A2 Herbicidal sulfonyl urea CIBA-GEIGY AG (CH) 1985-05-15 — — EP claimed
US-3954732-A BACTERICIDAL PENICILLINS FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1976-05-04 — — US claimed
Send feedback